A potential treatment for recent ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a new drug called HRS-4029 for people who have had an ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help improve recovery when given very soon after the stroke starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had an ischemic stroke (a stroke from a blocked blood vessel) within the last 3 hours.
- Before the stroke, you were able to care for yourself (score of 0 or 1 on a disability scale).
- Your stroke symptoms are moderate to severe (score between 6 and 25 on a stroke severity test).
- You have some weakness in an arm or leg (score of at least 2 on the limb strength part).
- You do not have bleeding in the brain or other serious medical conditions that would make the trial unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called HRS-4029 in healthy people to see how safe it is and how the body handles it. It is an early-stage study that may help in developing a treatment for future patients.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests an investigational drug called B2065 for people who have had a recent ischemic stroke (a stroke caused by a blockage in a blood vessel in the brain). The goal is to see if it is safe and if it might help improve recovery when given within 36 hours of stroke symptoms starting.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.
This trial tests an investigational drug, QHRD106, given as an injection for people who have had a moderate-to-severe acute ischemic stroke. It aims to see if the drug can help recovery when given within 24 hours after the stroke starts, and it is for patients who are not receiving standard clot-busting treatment.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.